nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1B1—glaucoma	0.526	1	CbGaD
Flutamide—CYP1A1—Clonidine—glaucoma	0.0485	0.163	CbGbCtD
Flutamide—CYP1A2—Betaxolol—glaucoma	0.0396	0.133	CbGbCtD
Flutamide—CYP2C19—Methazolamide—glaucoma	0.0325	0.109	CbGbCtD
Flutamide—CYP3A5—Clonidine—glaucoma	0.0291	0.0978	CbGbCtD
Flutamide—CYP2C19—Timolol—glaucoma	0.0276	0.0928	CbGbCtD
Flutamide—CYP3A4—Pilocarpine—glaucoma	0.0233	0.0781	CbGbCtD
Flutamide—CYP1A2—Clonidine—glaucoma	0.0217	0.0728	CbGbCtD
Flutamide—CYP3A4—Brinzolamide—glaucoma	0.0183	0.0613	CbGbCtD
Flutamide—CYP3A4—Dorzolamide—glaucoma	0.0176	0.0592	CbGbCtD
Flutamide—CYP3A4—Methazolamide—glaucoma	0.0157	0.0528	CbGbCtD
Flutamide—CYP3A4—Acetazolamide—glaucoma	0.0126	0.0422	CbGbCtD
Flutamide—CYP3A4—Clonidine—glaucoma	0.0114	0.0381	CbGbCtD
Flutamide—Dizziness—Diclofenamide—glaucoma	0.000343	0.00247	CcSEcCtD
Flutamide—Asthenia—Methazolamide—glaucoma	0.000342	0.00247	CcSEcCtD
Flutamide—Diarrhoea—Levobunolol—glaucoma	0.000341	0.00246	CcSEcCtD
Flutamide—Nervousness—Pilocarpine—glaucoma	0.00034	0.00246	CcSEcCtD
Flutamide—Discomfort—Acetazolamide—glaucoma	0.00034	0.00246	CcSEcCtD
Flutamide—Ill-defined disorder—Brinzolamide—glaucoma	0.000338	0.00244	CcSEcCtD
Flutamide—Nausea—Metipranolol—glaucoma	0.000338	0.00244	CcSEcCtD
Flutamide—Hypertension—Brimonidine—glaucoma	0.000335	0.00242	CcSEcCtD
Flutamide—Dizziness—Carbachol—glaucoma	0.000334	0.00241	CcSEcCtD
Flutamide—Insomnia—Apraclonidine—glaucoma	0.000334	0.00241	CcSEcCtD
Flutamide—Malaise—Travoprost—glaucoma	0.000333	0.0024	CcSEcCtD
Flutamide—Confusional state—Acetazolamide—glaucoma	0.000333	0.0024	CcSEcCtD
Flutamide—Headache—Carteolol—glaucoma	0.00033	0.00238	CcSEcCtD
Flutamide—Anxiety—Brimonidine—glaucoma	0.000329	0.00238	CcSEcCtD
Flutamide—Vomiting—Diclofenamide—glaucoma	0.000329	0.00238	CcSEcCtD
Flutamide—Dizziness—Levobunolol—glaucoma	0.000329	0.00238	CcSEcCtD
Flutamide—Malaise—Brinzolamide—glaucoma	0.000329	0.00237	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000328	0.00237	CcSEcCtD
Flutamide—Somnolence—Apraclonidine—glaucoma	0.000328	0.00237	CcSEcCtD
Flutamide—Disturbance in sexual arousal—Timolol—glaucoma	0.000328	0.00237	CcSEcCtD
Flutamide—Pruritus—Latanoprost—glaucoma	0.000327	0.00236	CcSEcCtD
Flutamide—Rash—Diclofenamide—glaucoma	0.000327	0.00236	CcSEcCtD
Flutamide—Discomfort—Brimonidine—glaucoma	0.000327	0.00236	CcSEcCtD
Flutamide—Diarrhoea—Methazolamide—glaucoma	0.000326	0.00236	CcSEcCtD
Flutamide—Headache—Diclofenamide—glaucoma	0.000325	0.00234	CcSEcCtD
Flutamide—Insomnia—Bimatoprost—glaucoma	0.000324	0.00234	CcSEcCtD
Flutamide—Thrombocytopenia—Acetazolamide—glaucoma	0.000323	0.00233	CcSEcCtD
Flutamide—Erectile dysfunction—Betaxolol—glaucoma	0.000322	0.00232	CcSEcCtD
Flutamide—Vomiting—Carbachol—glaucoma	0.000322	0.00232	CcSEcCtD
Flutamide—Hepatitis—Clonidine—glaucoma	0.000321	0.00232	CcSEcCtD
Flutamide—Hypertension—Dorzolamide—glaucoma	0.00032	0.00231	CcSEcCtD
Flutamide—Rash—Carbachol—glaucoma	0.000319	0.0023	CcSEcCtD
Flutamide—Hypertension—Travoprost—glaucoma	0.000319	0.0023	CcSEcCtD
Flutamide—Dermatitis—Carbachol—glaucoma	0.000319	0.0023	CcSEcCtD
Flutamide—Fatigue—Apraclonidine—glaucoma	0.000318	0.0023	CcSEcCtD
Flutamide—Somnolence—Bimatoprost—glaucoma	0.000318	0.0023	CcSEcCtD
Flutamide—Oedema—Brimonidine—glaucoma	0.000317	0.00229	CcSEcCtD
Flutamide—Headache—Carbachol—glaucoma	0.000317	0.00229	CcSEcCtD
Flutamide—Constipation—Apraclonidine—glaucoma	0.000316	0.00228	CcSEcCtD
Flutamide—Hyperglycaemia—Betaxolol—glaucoma	0.000315	0.00228	CcSEcCtD
Flutamide—Hypertension—Brinzolamide—glaucoma	0.000315	0.00227	CcSEcCtD
Flutamide—Anxiety—Dorzolamide—glaucoma	0.000315	0.00227	CcSEcCtD
Flutamide—Leukopenia—Pilocarpine—glaucoma	0.000314	0.00226	CcSEcCtD
Flutamide—Anxiety—Travoprost—glaucoma	0.000313	0.00226	CcSEcCtD
Flutamide—Nausea—Carteolol—glaucoma	0.000313	0.00226	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000312	0.00225	CcSEcCtD
Flutamide—Headache—Levobunolol—glaucoma	0.000312	0.00225	CcSEcCtD
Flutamide—Discomfort—Dorzolamide—glaucoma	0.000312	0.00225	CcSEcCtD
Flutamide—Discomfort—Travoprost—glaucoma	0.000311	0.00224	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000308	0.00222	CcSEcCtD
Flutamide—Skin disorder—Brimonidine—glaucoma	0.000308	0.00222	CcSEcCtD
Flutamide—Nausea—Diclofenamide—glaucoma	0.000308	0.00222	CcSEcCtD
Flutamide—Discomfort—Brinzolamide—glaucoma	0.000307	0.00221	CcSEcCtD
Flutamide—Dizziness—Latanoprost—glaucoma	0.000305	0.0022	CcSEcCtD
Flutamide—Confusional state—Dorzolamide—glaucoma	0.000305	0.0022	CcSEcCtD
Flutamide—Feeling abnormal—Apraclonidine—glaucoma	0.000304	0.0022	CcSEcCtD
Flutamide—Vomiting—Methazolamide—glaucoma	0.000303	0.00219	CcSEcCtD
Flutamide—Oedema—Dorzolamide—glaucoma	0.000303	0.00218	CcSEcCtD
Flutamide—Hypertension—Pilocarpine—glaucoma	0.000303	0.00218	CcSEcCtD
Flutamide—Oedema—Travoprost—glaucoma	0.000301	0.00217	CcSEcCtD
Flutamide—Rash—Methazolamide—glaucoma	0.000301	0.00217	CcSEcCtD
Flutamide—Dermatitis—Methazolamide—glaucoma	0.000301	0.00217	CcSEcCtD
Flutamide—Nausea—Carbachol—glaucoma	0.0003	0.00217	CcSEcCtD
Flutamide—Headache—Methazolamide—glaucoma	0.000299	0.00216	CcSEcCtD
Flutamide—Anxiety—Pilocarpine—glaucoma	0.000297	0.00215	CcSEcCtD
Flutamide—Nausea—Levobunolol—glaucoma	0.000296	0.00213	CcSEcCtD
Flutamide—Discomfort—Pilocarpine—glaucoma	0.000295	0.00213	CcSEcCtD
Flutamide—Somnolence—Acetazolamide—glaucoma	0.000294	0.00212	CcSEcCtD
Flutamide—Skin disorder—Travoprost—glaucoma	0.000293	0.00211	CcSEcCtD
Flutamide—Rash—Latanoprost—glaucoma	0.000291	0.0021	CcSEcCtD
Flutamide—Dermatitis—Latanoprost—glaucoma	0.000291	0.0021	CcSEcCtD
Flutamide—Headache—Latanoprost—glaucoma	0.000289	0.00209	CcSEcCtD
Flutamide—Skin disorder—Brinzolamide—glaucoma	0.000289	0.00209	CcSEcCtD
Flutamide—Anorexia—Dorzolamide—glaucoma	0.000289	0.00208	CcSEcCtD
Flutamide—Confusional state—Pilocarpine—glaucoma	0.000288	0.00208	CcSEcCtD
Flutamide—Decreased appetite—Acetazolamide—glaucoma	0.000287	0.00207	CcSEcCtD
Flutamide—Insomnia—Brimonidine—glaucoma	0.000287	0.00207	CcSEcCtD
Flutamide—Oedema—Pilocarpine—glaucoma	0.000286	0.00206	CcSEcCtD
Flutamide—Fatigue—Acetazolamide—glaucoma	0.000285	0.00205	CcSEcCtD
Flutamide—Nausea—Methazolamide—glaucoma	0.000283	0.00204	CcSEcCtD
Flutamide—Somnolence—Brimonidine—glaucoma	0.000282	0.00203	CcSEcCtD
Flutamide—Thrombocytopenia—Pilocarpine—glaucoma	0.00028	0.00202	CcSEcCtD
Flutamide—Erythema—Clonidine—glaucoma	0.00028	0.00202	CcSEcCtD
Flutamide—Tension—Clonidine—glaucoma	0.000275	0.00198	CcSEcCtD
Flutamide—Insomnia—Dorzolamide—glaucoma	0.000274	0.00198	CcSEcCtD
Flutamide—Fatigue—Brimonidine—glaucoma	0.000273	0.00197	CcSEcCtD
Flutamide—Anorexia—Pilocarpine—glaucoma	0.000273	0.00197	CcSEcCtD
Flutamide—Feeling abnormal—Acetazolamide—glaucoma	0.000272	0.00196	CcSEcCtD
Flutamide—Nervousness—Clonidine—glaucoma	0.000272	0.00196	CcSEcCtD
Flutamide—Insomnia—Brinzolamide—glaucoma	0.000269	0.00194	CcSEcCtD
Flutamide—Somnolence—Dorzolamide—glaucoma	0.000269	0.00194	CcSEcCtD
Flutamide—Asthenia—Apraclonidine—glaucoma	0.000265	0.00191	CcSEcCtD
Flutamide—Somnolence—Brinzolamide—glaucoma	0.000265	0.00191	CcSEcCtD
Flutamide—Decreased appetite—Dorzolamide—glaucoma	0.000263	0.0019	CcSEcCtD
Flutamide—Erectile dysfunction—Timolol—glaucoma	0.000263	0.0019	CcSEcCtD
Flutamide—Pruritus—Apraclonidine—glaucoma	0.000261	0.00188	CcSEcCtD
Flutamide—Fatigue—Dorzolamide—glaucoma	0.000261	0.00188	CcSEcCtD
Flutamide—Fatigue—Travoprost—glaucoma	0.00026	0.00187	CcSEcCtD
Flutamide—Ill-defined disorder—Clonidine—glaucoma	0.00026	0.00187	CcSEcCtD
Flutamide—Insomnia—Pilocarpine—glaucoma	0.000259	0.00187	CcSEcCtD
Flutamide—Decreased appetite—Brinzolamide—glaucoma	0.000259	0.00187	CcSEcCtD
Flutamide—Constipation—Travoprost—glaucoma	0.000258	0.00186	CcSEcCtD
Flutamide—Hyperglycaemia—Timolol—glaucoma	0.000258	0.00186	CcSEcCtD
Flutamide—Asthenia—Bimatoprost—glaucoma	0.000257	0.00185	CcSEcCtD
Flutamide—Fatigue—Brinzolamide—glaucoma	0.000257	0.00185	CcSEcCtD
Flutamide—Somnolence—Pilocarpine—glaucoma	0.000254	0.00183	CcSEcCtD
Flutamide—Pruritus—Bimatoprost—glaucoma	0.000253	0.00183	CcSEcCtD
Flutamide—Diarrhoea—Apraclonidine—glaucoma	0.000253	0.00182	CcSEcCtD
Flutamide—Malaise—Clonidine—glaucoma	0.000252	0.00182	CcSEcCtD
Flutamide—Feeling abnormal—Dorzolamide—glaucoma	0.000249	0.0018	CcSEcCtD
Flutamide—Decreased appetite—Pilocarpine—glaucoma	0.000249	0.00179	CcSEcCtD
Flutamide—Feeling abnormal—Travoprost—glaucoma	0.000248	0.00179	CcSEcCtD
Flutamide—Feeling abnormal—Brinzolamide—glaucoma	0.000245	0.00177	CcSEcCtD
Flutamide—Constipation—Pilocarpine—glaucoma	0.000245	0.00176	CcSEcCtD
Flutamide—Dizziness—Apraclonidine—glaucoma	0.000244	0.00176	CcSEcCtD
Flutamide—Erythema—Betaxolol—glaucoma	0.000244	0.00176	CcSEcCtD
Flutamide—Tension—Betaxolol—glaucoma	0.000239	0.00173	CcSEcCtD
Flutamide—Anxiety—Clonidine—glaucoma	0.000237	0.00171	CcSEcCtD
Flutamide—Asthenia—Acetazolamide—glaucoma	0.000237	0.00171	CcSEcCtD
Flutamide—Dizziness—Bimatoprost—glaucoma	0.000237	0.00171	CcSEcCtD
Flutamide—Nervousness—Betaxolol—glaucoma	0.000237	0.00171	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000237	0.00171	CcSEcCtD
Flutamide—Feeling abnormal—Pilocarpine—glaucoma	0.000236	0.0017	CcSEcCtD
Flutamide—Discomfort—Clonidine—glaucoma	0.000235	0.0017	CcSEcCtD
Flutamide—Vomiting—Apraclonidine—glaucoma	0.000235	0.00169	CcSEcCtD
Flutamide—Dermatitis—Apraclonidine—glaucoma	0.000233	0.00168	CcSEcCtD
Flutamide—Headache—Apraclonidine—glaucoma	0.000231	0.00167	CcSEcCtD
Flutamide—Confusional state—Clonidine—glaucoma	0.00023	0.00166	CcSEcCtD
Flutamide—Oedema—Clonidine—glaucoma	0.000228	0.00165	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—FAS—glaucoma	0.000227	0.00605	CbGpPWpGaD
Flutamide—Asthenia—Brimonidine—glaucoma	0.000227	0.00164	CcSEcCtD
Flutamide—Ill-defined disorder—Betaxolol—glaucoma	0.000226	0.00163	CcSEcCtD
Flutamide—Diarrhoea—Acetazolamide—glaucoma	0.000226	0.00163	CcSEcCtD
Flutamide—Rash—Bimatoprost—glaucoma	0.000226	0.00163	CcSEcCtD
Flutamide—Dermatitis—Bimatoprost—glaucoma	0.000225	0.00163	CcSEcCtD
Flutamide—Oedema peripheral—Timolol—glaucoma	0.000225	0.00163	CcSEcCtD
Flutamide—Anaemia—Betaxolol—glaucoma	0.000225	0.00162	CcSEcCtD
Flutamide—Pruritus—Brimonidine—glaucoma	0.000224	0.00162	CcSEcCtD
Flutamide—Headache—Bimatoprost—glaucoma	0.000224	0.00162	CcSEcCtD
Flutamide—CYP1A1—Oxidative Stress—SOD1—glaucoma	0.000224	0.00595	CbGpPWpGaD
Flutamide—Thrombocytopenia—Clonidine—glaucoma	0.000224	0.00161	CcSEcCtD
Flutamide—Skin disorder—Clonidine—glaucoma	0.000222	0.0016	CcSEcCtD
Flutamide—Malaise—Betaxolol—glaucoma	0.00022	0.00159	CcSEcCtD
Flutamide—Nausea—Apraclonidine—glaucoma	0.000219	0.00158	CcSEcCtD
Flutamide—Dizziness—Acetazolamide—glaucoma	0.000218	0.00158	CcSEcCtD
Flutamide—Anorexia—Clonidine—glaucoma	0.000218	0.00157	CcSEcCtD
Flutamide—Asthenia—Dorzolamide—glaucoma	0.000217	0.00157	CcSEcCtD
Flutamide—Asthenia—Travoprost—glaucoma	0.000216	0.00156	CcSEcCtD
Flutamide—Pruritus—Dorzolamide—glaucoma	0.000214	0.00155	CcSEcCtD
Flutamide—Asthenia—Brinzolamide—glaucoma	0.000214	0.00154	CcSEcCtD
Flutamide—Pruritus—Travoprost—glaucoma	0.000213	0.00154	CcSEcCtD
Flutamide—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000213	0.00567	CbGpPWpGaD
Flutamide—Nausea—Bimatoprost—glaucoma	0.000213	0.00153	CcSEcCtD
Flutamide—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000211	0.00562	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—glaucoma	0.000211	0.00562	CbGpPWpGaD
Flutamide—Pruritus—Brinzolamide—glaucoma	0.000211	0.00152	CcSEcCtD
Flutamide—Vomiting—Acetazolamide—glaucoma	0.00021	0.00152	CcSEcCtD
Flutamide—Dizziness—Brimonidine—glaucoma	0.00021	0.00151	CcSEcCtD
Flutamide—CYP1A1—Melatonin metabolism and effects—EDN1—glaucoma	0.000209	0.00555	CbGpPWpGaD
Flutamide—Diarrhoea—Dorzolamide—glaucoma	0.000207	0.00149	CcSEcCtD
Flutamide—Headache—Acetazolamide—glaucoma	0.000207	0.00149	CcSEcCtD
Flutamide—Anxiety—Betaxolol—glaucoma	0.000207	0.00149	CcSEcCtD
Flutamide—Insomnia—Clonidine—glaucoma	0.000207	0.00149	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000206	0.00549	CbGpPWpGaD
Flutamide—Diarrhoea—Travoprost—glaucoma	0.000206	0.00149	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000206	0.00149	CcSEcCtD
Flutamide—Asthenia—Pilocarpine—glaucoma	0.000205	0.00148	CcSEcCtD
Flutamide—Discomfort—Betaxolol—glaucoma	0.000205	0.00148	CcSEcCtD
Flutamide—Diarrhoea—Brinzolamide—glaucoma	0.000204	0.00147	CcSEcCtD
Flutamide—Somnolence—Clonidine—glaucoma	0.000203	0.00147	CcSEcCtD
Flutamide—Pruritus—Pilocarpine—glaucoma	0.000202	0.00146	CcSEcCtD
Flutamide—Confusional state—Betaxolol—glaucoma	0.000201	0.00145	CcSEcCtD
Flutamide—Dizziness—Dorzolamide—glaucoma	0.0002	0.00144	CcSEcCtD
Flutamide—Rash—Brimonidine—glaucoma	0.0002	0.00144	CcSEcCtD
Flutamide—Dermatitis—Brimonidine—glaucoma	0.0002	0.00144	CcSEcCtD
Flutamide—Dizziness—Travoprost—glaucoma	0.000199	0.00144	CcSEcCtD
Flutamide—Erythema—Timolol—glaucoma	0.000199	0.00144	CcSEcCtD
Flutamide—Oedema—Betaxolol—glaucoma	0.000199	0.00143	CcSEcCtD
Flutamide—Headache—Brimonidine—glaucoma	0.000199	0.00143	CcSEcCtD
Flutamide—Decreased appetite—Clonidine—glaucoma	0.000199	0.00143	CcSEcCtD
Flutamide—Fatigue—Clonidine—glaucoma	0.000197	0.00142	CcSEcCtD
Flutamide—Dizziness—Brinzolamide—glaucoma	0.000197	0.00142	CcSEcCtD
Flutamide—Nausea—Acetazolamide—glaucoma	0.000196	0.00142	CcSEcCtD
Flutamide—Diarrhoea—Pilocarpine—glaucoma	0.000196	0.00141	CcSEcCtD
Flutamide—Tension—Timolol—glaucoma	0.000195	0.00141	CcSEcCtD
Flutamide—Constipation—Clonidine—glaucoma	0.000195	0.00141	CcSEcCtD
Flutamide—Thrombocytopenia—Betaxolol—glaucoma	0.000195	0.0014	CcSEcCtD
Flutamide—Nervousness—Timolol—glaucoma	0.000193	0.00139	CcSEcCtD
Flutamide—Skin disorder—Betaxolol—glaucoma	0.000193	0.00139	CcSEcCtD
Flutamide—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000193	0.00512	CbGpPWpGaD
Flutamide—Vomiting—Dorzolamide—glaucoma	0.000192	0.00139	CcSEcCtD
Flutamide—Rash—Dorzolamide—glaucoma	0.000191	0.00138	CcSEcCtD
Flutamide—Dermatitis—Dorzolamide—glaucoma	0.000191	0.00138	CcSEcCtD
Flutamide—Rash—Travoprost—glaucoma	0.00019	0.00137	CcSEcCtD
Flutamide—Dermatitis—Travoprost—glaucoma	0.00019	0.00137	CcSEcCtD
Flutamide—Headache—Dorzolamide—glaucoma	0.00019	0.00137	CcSEcCtD
Flutamide—Anorexia—Betaxolol—glaucoma	0.00019	0.00137	CcSEcCtD
Flutamide—Vomiting—Brinzolamide—glaucoma	0.000189	0.00137	CcSEcCtD
Flutamide—Dizziness—Pilocarpine—glaucoma	0.000189	0.00136	CcSEcCtD
Flutamide—Headache—Travoprost—glaucoma	0.000189	0.00136	CcSEcCtD
Flutamide—Nausea—Brimonidine—glaucoma	0.000188	0.00136	CcSEcCtD
Flutamide—Feeling abnormal—Clonidine—glaucoma	0.000188	0.00136	CcSEcCtD
Flutamide—Rash—Brinzolamide—glaucoma	0.000188	0.00135	CcSEcCtD
Flutamide—Dermatitis—Brinzolamide—glaucoma	0.000187	0.00135	CcSEcCtD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000187	0.00498	CbGpPWpGaD
Flutamide—Headache—Brinzolamide—glaucoma	0.000186	0.00135	CcSEcCtD
Flutamide—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000186	0.00495	CbGpPWpGaD
Flutamide—Vomiting—Pilocarpine—glaucoma	0.000182	0.00131	CcSEcCtD
Flutamide—Rash—Pilocarpine—glaucoma	0.00018	0.0013	CcSEcCtD
Flutamide—Dermatitis—Pilocarpine—glaucoma	0.00018	0.0013	CcSEcCtD
Flutamide—Insomnia—Betaxolol—glaucoma	0.00018	0.0013	CcSEcCtD
Flutamide—Nausea—Dorzolamide—glaucoma	0.00018	0.0013	CcSEcCtD
Flutamide—Headache—Pilocarpine—glaucoma	0.000179	0.00129	CcSEcCtD
Flutamide—Nausea—Travoprost—glaucoma	0.000179	0.00129	CcSEcCtD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000178	0.00474	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000178	0.00474	CbGpPWpGaD
Flutamide—CYP1A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000178	0.00474	CbGpPWpGaD
Flutamide—Nausea—Brinzolamide—glaucoma	0.000177	0.00128	CcSEcCtD
Flutamide—Decreased appetite—Betaxolol—glaucoma	0.000173	0.00125	CcSEcCtD
Flutamide—Hypertension—Timolol—glaucoma	0.000172	0.00124	CcSEcCtD
Flutamide—Fatigue—Betaxolol—glaucoma	0.000171	0.00124	CcSEcCtD
Flutamide—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000171	0.00454	CbGpPWpGaD
Flutamide—Constipation—Betaxolol—glaucoma	0.00017	0.00123	CcSEcCtD
Flutamide—Nausea—Pilocarpine—glaucoma	0.00017	0.00123	CcSEcCtD
Flutamide—CYP1A1—Melatonin metabolism and effects—APOE—glaucoma	0.00017	0.00451	CbGpPWpGaD
Flutamide—Anxiety—Timolol—glaucoma	0.000169	0.00122	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000168	0.00121	CcSEcCtD
Flutamide—Discomfort—Timolol—glaucoma	0.000167	0.00121	CcSEcCtD
Flutamide—CYP1A1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000167	0.00444	CbGpPWpGaD
Flutamide—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000165	0.00438	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000164	0.00437	CbGpPWpGaD
Flutamide—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000164	0.00437	CbGpPWpGaD
Flutamide—Asthenia—Clonidine—glaucoma	0.000164	0.00118	CcSEcCtD
Flutamide—Feeling abnormal—Betaxolol—glaucoma	0.000164	0.00118	CcSEcCtD
Flutamide—Confusional state—Timolol—glaucoma	0.000164	0.00118	CcSEcCtD
Flutamide—Oedema—Timolol—glaucoma	0.000162	0.00117	CcSEcCtD
Flutamide—Pruritus—Clonidine—glaucoma	0.000162	0.00117	CcSEcCtD
Flutamide—Skin disorder—Timolol—glaucoma	0.000158	0.00114	CcSEcCtD
Flutamide—Diarrhoea—Clonidine—glaucoma	0.000156	0.00113	CcSEcCtD
Flutamide—Anorexia—Timolol—glaucoma	0.000155	0.00112	CcSEcCtD
Flutamide—AR—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000155	0.00411	CbGpPWpGaD
Flutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000153	0.00406	CbGpPWpGaD
Flutamide—Dizziness—Clonidine—glaucoma	0.000151	0.00109	CcSEcCtD
Flutamide—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000151	0.00401	CbGpPWpGaD
Flutamide—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000149	0.00395	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000148	0.00393	CbGpPWpGaD
Flutamide—Insomnia—Timolol—glaucoma	0.000147	0.00106	CcSEcCtD
Flutamide—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.000147	0.0039	CbGpPWpGaD
Flutamide—Vomiting—Clonidine—glaucoma	0.000145	0.00105	CcSEcCtD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000145	0.00385	CbGpPWpGaD
Flutamide—Somnolence—Timolol—glaucoma	0.000144	0.00104	CcSEcCtD
Flutamide—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000144	0.00384	CbGpPWpGaD
Flutamide—Rash—Clonidine—glaucoma	0.000144	0.00104	CcSEcCtD
Flutamide—Dermatitis—Clonidine—glaucoma	0.000144	0.00104	CcSEcCtD
Flutamide—Headache—Clonidine—glaucoma	0.000143	0.00103	CcSEcCtD
Flutamide—Asthenia—Betaxolol—glaucoma	0.000143	0.00103	CcSEcCtD
Flutamide—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000142	0.00379	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000142	0.00377	CbGpPWpGaD
Flutamide—Decreased appetite—Timolol—glaucoma	0.000141	0.00102	CcSEcCtD
Flutamide—Pruritus—Betaxolol—glaucoma	0.000141	0.00102	CcSEcCtD
Flutamide—Fatigue—Timolol—glaucoma	0.00014	0.00101	CcSEcCtD
Flutamide—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000139	0.00369	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000137	0.00365	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—TNF—glaucoma	0.000137	0.00364	CbGpPWpGaD
Flutamide—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000137	0.00363	CbGpPWpGaD
Flutamide—Diarrhoea—Betaxolol—glaucoma	0.000136	0.000982	CcSEcCtD
Flutamide—Nausea—Clonidine—glaucoma	0.000136	0.000979	CcSEcCtD
Flutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	0.000134	0.00358	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CAV1—glaucoma	0.000134	0.00357	CbGpPWpGaD
Flutamide—Feeling abnormal—Timolol—glaucoma	0.000134	0.000966	CcSEcCtD
Flutamide—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000133	0.00354	CbGpPWpGaD
Flutamide—Dizziness—Betaxolol—glaucoma	0.000131	0.000949	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000131	0.00347	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—GSTT1—glaucoma	0.000127	0.00337	CbGpPWpGaD
Flutamide—Vomiting—Betaxolol—glaucoma	0.000126	0.000912	CcSEcCtD
Flutamide—Rash—Betaxolol—glaucoma	0.000125	0.000905	CcSEcCtD
Flutamide—Dermatitis—Betaxolol—glaucoma	0.000125	0.000904	CcSEcCtD
Flutamide—Headache—Betaxolol—glaucoma	0.000125	0.000899	CcSEcCtD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000124	0.00329	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000124	0.00329	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000124	0.00329	CbGpPWpGaD
Flutamide—CYP1B1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000122	0.00325	CbGpPWpGaD
Flutamide—Nausea—Betaxolol—glaucoma	0.000118	0.000852	CcSEcCtD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.000118	0.00314	CbGpPWpGaD
Flutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000118	0.00314	CbGpPWpGaD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000117	0.00311	CbGpPWpGaD
Flutamide—Asthenia—Timolol—glaucoma	0.000117	0.000841	CcSEcCtD
Flutamide—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000116	0.0031	CbGpPWpGaD
Flutamide—Pruritus—Timolol—glaucoma	0.000115	0.000829	CcSEcCtD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000114	0.00303	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000114	0.00303	CbGpPWpGaD
Flutamide—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000114	0.00303	CbGpPWpGaD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000112	0.00297	CbGpPWpGaD
Flutamide—Diarrhoea—Timolol—glaucoma	0.000111	0.000802	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00011	0.00293	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.000108	0.00288	CbGpPWpGaD
Flutamide—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000108	0.00288	CbGpPWpGaD
Flutamide—Dizziness—Timolol—glaucoma	0.000107	0.000775	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000107	0.00285	CbGpPWpGaD
Flutamide—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000106	0.00283	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000106	0.00281	CbGpPWpGaD
Flutamide—Vomiting—Timolol—glaucoma	0.000103	0.000745	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000103	0.00274	CbGpPWpGaD
Flutamide—Rash—Timolol—glaucoma	0.000102	0.000739	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000102	0.00272	CbGpPWpGaD
Flutamide—Dermatitis—Timolol—glaucoma	0.000102	0.000738	CcSEcCtD
Flutamide—Headache—Timolol—glaucoma	0.000102	0.000734	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—NGF—glaucoma	9.78e-05	0.0026	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	9.73e-05	0.00259	CbGpPWpGaD
Flutamide—Nausea—Timolol—glaucoma	9.65e-05	0.000696	CcSEcCtD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.57e-05	0.00254	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	9.43e-05	0.00251	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.42e-05	0.00251	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	9.37e-05	0.00249	CbGpPWpGaD
Flutamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.2e-05	0.00245	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	9.18e-05	0.00244	CbGpPWpGaD
Flutamide—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.08e-05	0.00241	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	8.88e-05	0.00236	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	8.88e-05	0.00236	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NARFL—glaucoma	8.87e-05	0.00236	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CA5A—glaucoma	8.87e-05	0.00236	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	8.81e-05	0.00234	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—glaucoma	8.81e-05	0.00234	CbGpPWpGaD
Flutamide—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	8.78e-05	0.00233	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	8.69e-05	0.00231	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TP53—glaucoma	8.51e-05	0.00226	CbGpPWpGaD
Flutamide—CYP1A2—Phase II conjugation—GSTT1—glaucoma	8.5e-05	0.00226	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	8.28e-05	0.0022	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—GSTT1—glaucoma	8.25e-05	0.00219	CbGpPWpGaD
Flutamide—CYP1B1—Biological oxidations—GSTM1—glaucoma	8.06e-05	0.00214	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	8.04e-05	0.00214	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	8.02e-05	0.00213	CbGpPWpGaD
Flutamide—CYP1B1—Metapathway biotransformation—GSTM1—glaucoma	7.95e-05	0.00212	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—GSTT1—glaucoma	7.79e-05	0.00207	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	7.61e-05	0.00203	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	7.61e-05	0.00203	CbGpPWpGaD
Flutamide—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	7.52e-05	0.002	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.45e-05	0.00198	CbGpPWpGaD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.1e-05	0.00189	CbGpPWpGaD
Flutamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7e-05	0.00186	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.86e-05	0.00182	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—CYP1B1—glaucoma	6.57e-05	0.00175	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	6.48e-05	0.00172	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GSTT1—glaucoma	6.38e-05	0.0017	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	6.33e-05	0.00168	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—CYP1B1—glaucoma	6.21e-05	0.00165	CbGpPWpGaD
Flutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	6.15e-05	0.00164	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	6.13e-05	0.00163	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	5.99e-05	0.00159	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.8e-05	0.00154	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NARFL—glaucoma	5.78e-05	0.00154	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA5A—glaucoma	5.78e-05	0.00154	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.75e-05	0.00153	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA5A—glaucoma	5.46e-05	0.00145	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NARFL—glaucoma	5.46e-05	0.00145	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	5.43e-05	0.00144	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	5.43e-05	0.00144	CbGpPWpGaD
Flutamide—CYP1A2—Phase II conjugation—GSTM1—glaucoma	5.41e-05	0.00144	CbGpPWpGaD
Flutamide—CYP3A5—Biological oxidations—GSTM1—glaucoma	5.26e-05	0.0014	CbGpPWpGaD
Flutamide—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	5.18e-05	0.00138	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	5.13e-05	0.00136	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—CYP1B1—glaucoma	5.08e-05	0.00135	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	5.04e-05	0.00134	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	5.01e-05	0.00133	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.97e-05	0.00132	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—GSTM1—glaucoma	4.96e-05	0.00132	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	4.9e-05	0.0013	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.86e-05	0.00129	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.86e-05	0.00129	CbGpPWpGaD
Flutamide—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.8e-05	0.00128	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	4.8e-05	0.00128	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.78e-05	0.00127	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.75e-05	0.00126	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—CDKN2B—glaucoma	4.69e-05	0.00125	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.67e-05	0.00124	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA5A—glaucoma	4.47e-05	0.00119	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NARFL—glaucoma	4.47e-05	0.00119	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CA1—glaucoma	4.33e-05	0.00115	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CTSA—glaucoma	4.2e-05	0.00112	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NR3C1—glaucoma	4.11e-05	0.00109	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GSTM1—glaucoma	4.06e-05	0.00108	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	4.04e-05	0.00107	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	4.01e-05	0.00107	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—glaucoma	4e-05	0.00107	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.97e-05	0.00106	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CA2—glaucoma	3.96e-05	0.00105	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.96e-05	0.00105	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.91e-05	0.00104	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.87e-05	0.00103	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.84e-05	0.00102	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.7e-05	0.000984	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	3.62e-05	0.000964	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NARFL—glaucoma	3.48e-05	0.000927	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA5A—glaucoma	3.48e-05	0.000927	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.46e-05	0.000921	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.46e-05	0.000921	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.41e-05	0.000906	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.17e-05	0.000842	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.12e-05	0.000831	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.06e-05	0.000813	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.01e-05	0.000802	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3e-05	0.000799	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA1—glaucoma	2.82e-05	0.000751	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—TXN—glaucoma	2.79e-05	0.000743	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CTSA—glaucoma	2.73e-05	0.000727	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NARFL—glaucoma	2.69e-05	0.000715	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA5A—glaucoma	2.69e-05	0.000715	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA1—glaucoma	2.67e-05	0.00071	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CTSA—glaucoma	2.58e-05	0.000687	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CA2—glaucoma	2.58e-05	0.000687	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.55e-05	0.000678	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.52e-05	0.000671	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.44e-05	0.00065	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CA2—glaucoma	2.44e-05	0.000649	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.41e-05	0.000641	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.38e-05	0.000634	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.38e-05	0.000634	CbGpPWpGaD
Flutamide—AR—Gene Expression—CDKN2B—glaucoma	2.26e-05	0.0006	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA1—glaucoma	2.18e-05	0.000581	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTT1—glaucoma	2.16e-05	0.000576	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CTSA—glaucoma	2.11e-05	0.000562	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CA2—glaucoma	2e-05	0.000531	CbGpPWpGaD
Flutamide—AR—Gene Expression—NR3C1—glaucoma	1.98e-05	0.000527	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.95e-05	0.000519	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.95e-05	0.000519	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TXN—glaucoma	1.82e-05	0.000484	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.75e-05	0.000464	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ABCA1—glaucoma	1.72e-05	0.000459	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TXN—glaucoma	1.72e-05	0.000457	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA1—glaucoma	1.7e-05	0.000452	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CTSA—glaucoma	1.65e-05	0.000438	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.57e-05	0.000417	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CA2—glaucoma	1.56e-05	0.000414	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.55e-05	0.000413	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.52e-05	0.000404	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.52e-05	0.000404	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTT1—glaucoma	1.41e-05	0.000375	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TXN—glaucoma	1.41e-05	0.000374	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTM1—glaucoma	1.38e-05	0.000367	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTT1—glaucoma	1.33e-05	0.000355	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA1—glaucoma	1.31e-05	0.000349	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.28e-05	0.000341	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.27e-05	0.000338	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CTSA—glaucoma	1.27e-05	0.000338	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—MTHFR—glaucoma	1.22e-05	0.000324	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA2—glaucoma	1.2e-05	0.000319	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—APOE—glaucoma	1.13e-05	0.000302	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1B1—glaucoma	1.12e-05	0.000299	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCA1—glaucoma	1.12e-05	0.000299	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CAV1—glaucoma	1.12e-05	0.000299	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TXN—glaucoma	1.1e-05	0.000292	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—glaucoma	1.09e-05	0.00029	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.07e-05	0.000286	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP1B1—glaucoma	1.06e-05	0.000283	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCA1—glaucoma	1.06e-05	0.000283	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1e-05	0.000266	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.91e-06	0.000264	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—glaucoma	8.99e-06	0.000239	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.8e-06	0.000234	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCA1—glaucoma	8.69e-06	0.000231	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1B1—glaucoma	8.69e-06	0.000231	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—glaucoma	8.5e-06	0.000226	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NOS3—glaucoma	8.5e-06	0.000226	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—glaucoma	8.49e-06	0.000226	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TXN—glaucoma	8.46e-06	0.000225	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—glaucoma	7.94e-06	0.000211	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—glaucoma	7.77e-06	0.000207	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—glaucoma	7.5e-06	0.0002	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—APOE—glaucoma	7.39e-06	0.000197	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CAV1—glaucoma	7.33e-06	0.000195	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—APOE—glaucoma	6.99e-06	0.000186	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—glaucoma	6.95e-06	0.000185	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CAV1—glaucoma	6.92e-06	0.000184	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.85e-06	0.000182	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1B1—glaucoma	6.77e-06	0.00018	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCA1—glaucoma	6.77e-06	0.00018	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—glaucoma	6.56e-06	0.000174	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—glaucoma	6.14e-06	0.000163	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—APOE—glaucoma	5.72e-06	0.000152	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CAV1—glaucoma	5.66e-06	0.000151	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NOS3—glaucoma	5.54e-06	0.000147	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—glaucoma	5.41e-06	0.000144	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NOS3—glaucoma	5.23e-06	0.000139	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1B1—glaucoma	5.23e-06	0.000139	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCA1—glaucoma	5.23e-06	0.000139	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—glaucoma	5.07e-06	0.000135	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—glaucoma	4.79e-06	0.000127	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—glaucoma	4.78e-06	0.000127	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—APOE—glaucoma	4.45e-06	0.000118	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CAV1—glaucoma	4.41e-06	0.000117	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NOS3—glaucoma	4.28e-06	0.000114	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—glaucoma	4.18e-06	0.000111	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—glaucoma	3.92e-06	0.000104	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—glaucoma	3.69e-06	9.82e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—APOE—glaucoma	3.44e-06	9.14e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CAV1—glaucoma	3.41e-06	9.06e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NOS3—glaucoma	3.34e-06	8.88e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—glaucoma	3.05e-06	8.12e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NOS3—glaucoma	2.58e-06	6.85e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—glaucoma	2.36e-06	6.27e-05	CbGpPWpGaD
